Uncategorized

UPDATE: Kailera breaks biotech IPO record with $625M debut

Published

on

Obesity-focused Kailera Therapeutics debuted on the Nasdaq Friday after raising a record $625 million, beating Moderna’s $600 million from 2018.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version